KEGG   PATHWAY: ptr05213
Entry
ptr05213                    Pathway                                
Name
Endometrial cancer - Pan troglodytes (chimpanzee)
Description
Endometrial cancer (EC) is the most common gynaecological malignancy and the fourth most common malignancy in women in the developed world after breast, colorectal and lung cancer. Two types of endometrial carcinoma are distinguished with respect to biology and clinical course. Type-I carcinoma is related to hyperestrogenism by association with endometrial hyperplasia, frequent expression of estrogen and progesterone receptors and younger age, whereas type-II carcinoma is unrelated to estrogen, associated with atrophic endometrium, frequent lack of estrogen and progesterone receptors and older age. The morphologic differences in these cancers are mirrored in their molecular genetic profile with type I showing defects in DNA-mismatch repair and mutations in PTEN, K-ras, and beta-catenin, and type II showing aneuploidy, p53 mutations, and her2/neu amplification.
Class
Human Diseases; Cancer: specific types
Pathway map
ptr05213  Endometrial cancer
ptr05213

Organism
Pan troglodytes (chimpanzee) [GN:ptr]
Gene
461435  EGF; pro-epidermal growth factor isoform X3 [KO:K04357]
463415  EGFR; epidermal growth factor receptor isoform X2 [KO:K04361] [EC:2.7.10.1]
460858  PIK3CA; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform [KO:K00922] [EC:2.7.1.153]
457922  PIK3CD; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
471079  PIK3CB; phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform isoform X1 [KO:K00922] [EC:2.7.1.153]
456565  PIK3R3; phosphatidylinositol 3-kinase regulatory subunit gamma isoform X2 [KO:K02649]
461836  PIK3R1; phosphatidylinositol 3-kinase regulatory subunit alpha isoform X2 [KO:K02649]
455855  PIK3R2; phosphatidylinositol 3-kinase regulatory subunit beta [KO:K02649]
466142  PTEN; phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN isoform X1 [KO:K01110] [EC:3.1.3.16 3.1.3.48 3.1.3.67]
467875  PDPK1; 3-phosphoinositide-dependent protein kinase 1 isoform X1 [KO:K06276] [EC:2.7.11.1]
112205915  LOW QUALITY PROTEIN: putative 3-phosphoinositide-dependent protein kinase 2 [KO:K06276] [EC:2.7.11.1]
748941  ILK; integrin-linked protein kinase isoform X2 [KO:K06272] [EC:2.7.11.1]
456035  AKT2; RAC-beta serine/threonine-protein kinase isoform X4 [KO:K04456] [EC:2.7.11.1]
740898  AKT1; RAC-alpha serine/threonine-protein kinase isoform X1 [KO:K04456] [EC:2.7.11.1]
100609583  AKT3; RAC-gamma serine/threonine-protein kinase [KO:K04456] [EC:2.7.11.1]
456457  CASP9; caspase-9 isoform X2 [KO:K04399] [EC:3.4.22.62]
100615623  BAD; bcl2-associated agonist of cell death [KO:K02158]
462921  FOXO3; forkhead box protein O3 [KO:K09408]
737245  GRB2; growth factor receptor-bound protein 2 [KO:K04364]
459171  SOS1; son of sevenless homolog 1 isoform X2 [KO:K03099]
452897  SOS2; son of sevenless homolog 2 isoform X1 [KO:K03099]
466302  HRAS; GTPase HRas isoform X1 [KO:K02833]
473387  KRAS; GTPase KRas isoform X1 [KO:K07827]
742713  NRAS; GTPase NRas [KO:K07828]
100614256  ARAF; serine/threonine-protein kinase A-Raf isoform X1 [KO:K08845] [EC:2.7.11.1]
463781  BRAF; serine/threonine-protein kinase B-raf isoform X2 [KO:K04365] [EC:2.7.11.1]
460182  RAF1; RAF proto-oncogene serine/threonine-protein kinase isoform X2 [KO:K04366] [EC:2.7.11.1]
450188  MAP2K1; dual specificity mitogen-activated protein kinase kinase 1 [KO:K04368] [EC:2.7.12.2]
456390  MAP2K2; dual specificity mitogen-activated protein kinase kinase 2 isoform X1 [KO:K04369] [EC:2.7.12.2]
454037  MAPK3; mitogen-activated protein kinase 3 isoform X1 [KO:K04371] [EC:2.7.11.24]
458680  MAPK1; mitogen-activated protein kinase 1 [KO:K04371] [EC:2.7.11.24]
473591  ELK1; ETS domain-containing protein Elk-1 [KO:K04375]
747104  MLH1; DNA mismatch repair protein Mlh1 isoform X1 [KO:K08734]
468009  CDH1; cadherin-1 isoform X1 [KO:K05689]
450183  CTNNB1; catenin beta-1 isoform X1 [KO:K02105]
450165  CTNNA1; catenin alpha-1 isoform X1 [KO:K05691]
459352  CTNNA2; catenin alpha-2 isoform X1 [KO:K05691]
746091  CTNNA3; catenin alpha-3 isoform X3 [KO:K05691]
453789  AXIN1; axin-1 isoform X1 [KO:K02157]
468301  AXIN2; axin-2 isoform X1 [KO:K04385]
461999  APC; adenomatous polyposis coli protein isoform X10 [KO:K02085]
455551  APC2; adenomatous polyposis coli protein 2 isoform X1 [KO:K02085]
100616510  GSK3B; glycogen synthase kinase-3 beta isoform X1 [KO:K03083] [EC:2.7.11.26]
745839  TCF7; LOW QUALITY PROTEIN: transcription factor 7 [KO:K02620]
744526  TCF7L1; transcription factor 7-like 1 isoform X2 [KO:K04490]
450743  TCF7L2; transcription factor 7-like 2 isoform X1 [KO:K04491]
461425  LEF1; lymphoid enhancer-binding factor 1 isoform X5 [KO:K04492]
464393  MYC; myc proto-oncogene protein [KO:K04377]
747442  CCND1; G1/S-specific cyclin-D1 [KO:K04503]
455214  TP53; cellular tumor antigen p53 isoform X2 [KO:K04451]
104001067  CDKN1A; cyclin-dependent kinase inhibitor 1 isoform X2 [KO:K06625]
464585  GADD45G; growth arrest and DNA damage-inducible protein GADD45 gamma [KO:K04402]
744311  GADD45B; growth arrest and DNA damage-inducible protein GADD45 beta [KO:K04402]
456929  GADD45A; growth arrest and DNA damage-inducible protein GADD45 alpha isoform X2 [KO:K04402]
747093  BAX; apoptosis regulator BAX isoform X1 [KO:K02159]
462616  BAK1; bcl-2 homologous antagonist/killer [KO:K14021]
451165  DDB2; DNA damage-binding protein 2 isoform X2 [KO:K10140]
461803  POLK; DNA polymerase kappa isoform X3 [KO:K03511] [EC:2.7.7.7]
454636  ERBB2; receptor tyrosine-protein kinase erbB-2 isoform X1 [KO:K05083] [EC:2.7.10.1]
Compound
C05981  Phosphatidylinositol-3,4,5-trisphosphate
Reference
  Authors
Ryan AJ, Susil B, Jobling TW, Oehler MK.
  Title
Endometrial cancer.
  Journal
Cell Tissue Res 322:53-61 (2005)
DOI:10.1007/s00441-005-1109-5
Reference
  Authors
Lax SF.
  Title
Molecular genetic pathways in various types of endometrial carcinoma: from a phenotypical to a molecular-based classification.
  Journal
Virchows Arch 444:213-23 (2004)
DOI:10.1007/s00428-003-0947-3
Reference
  Authors
Shiozawa T, Konishi I.
  Title
Early endometrial carcinoma: clinicopathology, hormonal aspects, molecular genetics, diagnosis, and treatment.
  Journal
Int J Clin Oncol 11:13-21 (2006)
DOI:10.1007/s10147-005-0546-1
Reference
  Authors
Hecht JL, Mutter GL.
  Title
Molecular and pathologic aspects of endometrial carcinogenesis.
  Journal
J Clin Oncol 24:4783-91 (2006)
DOI:10.1200/JCO.2006.06.7173
Reference
  Authors
Matias-Guiu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J.
  Title
Molecular pathology of endometrial hyperplasia and carcinoma.
  Journal
Hum Pathol 32:569-77 (2001)
DOI:10.1053/hupa.2001.25929
Reference
  Authors
Slomovitz BM, Broaddus RR, Burke TW, Sneige N, Soliman PT, Wu W, Sun CC, Munsell MF, Gershenson DM, Lu KH.
  Title
Her-2/neu overexpression and amplification in uterine papillary serous carcinoma.
  Journal
J Clin Oncol 22:3126-32 (2004)
DOI:10.1200/JCO.2004.11.154
Reference
PMID:7585656
  Authors
Saffari B, Jones LA, el-Naggar A, Felix JC, George J, Press MF.
  Title
Amplification and overexpression of HER-2/neu (c-erbB2) in endometrial cancers: correlation with overall survival.
  Journal
Cancer Res 55:5693-8 (1995)
Reference
  Authors
Kim D, Chung J.
  Title
Akt: versatile mediator of cell survival and beyond.
  Journal
J Biochem Mol Biol 35:106-15 (2002)
DOI:10.5483/bmbrep.2002.35.1.106
Related
pathway
ptr04010  MAPK signaling pathway
ptr04012  ErbB signaling pathway
ptr04060  Cytokine-cytokine receptor interaction
ptr04110  Cell cycle
ptr04115  p53 signaling pathway
ptr04151  PI3K-Akt signaling pathway
ptr04310  Wnt signaling pathway
ptr04520  Adherens junction
KO pathway
ko05213   
LinkDB

DBGET integrated database retrieval system